4th Quarter - Report

CROSSROADS STRATEGIES, LLC for GENENTECH, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Monitored H.J.RES.59, Continuing Appropriations Resolution, 2014.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.J.Res. 59 (113th)

Medicare/Medicaid MMM

Issues related to H.R.2810, Medicare Patient Access and Quality Improvement Act of 2013. Medicare reimbursement issues.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2810 (113th)

Health Issues HCR

S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R.1416, Cancer Patient Protection Act of 2013; S.957, Drug Supply Chain Security Act; H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; pharma supply chain issues.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1919 (113th), S. 959 (113th), S. 957 (113th), H.R. 1416 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.